Hobeika A - Search Results

1

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.

Hobeika A, Osada T, Serra D, Peplinski S, Hanson K, Tanaka Y, Niedzwiecki D, Chao N, Rizzieri D, Lyerly H, Clay T, Morse M. Hobeika A, et al. Cytotherapy. 2008;10(3):289-302. doi: 10.1080/14653240801927040. Cytotherapy. 2008. PMID: 18418774

2

Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.

Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Cumming RI, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly HK. Morse MA, et al. Among authors: hobeika a. J Clin Oncol. 2000 Dec 1;18(23):3883-93. doi: 10.1200/JCO.2000.18.23.3883. J Clin Oncol. 2000. PMID: 11099317 Clinical Trial.

3

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.

Osada T, Hsu D, Hammond S, Hobeika A, Devi G, Clay TM, Lyerly HK, Morse MA. Osada T, et al. Among authors: hobeika a. Br J Cancer. 2010 Jan 5;102(1):124-33. doi: 10.1038/sj.bjc.6605364. Epub 2009 Dec 1. Br J Cancer. 2010. PMID: 19953093 Free PMC article.

4

Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function.

Morse MA, Hobeika A, Serra D, Aird K, McKinney M, Aldrich A, Clay T, Mourich D, Lyerly HK, Iversen PL, Devi GR. Morse MA, et al. Among authors: hobeika a. Cancer Gene Ther. 2012 Jan;19(1):30-7. doi: 10.1038/cgt.2011.63. Epub 2011 Oct 14. Cancer Gene Ther. 2012. PMID: 21997230

5

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).

Zhao Y, Qiao G, Wang X, Song Y, Zhou X, Jiang N, Zhou L, Huang H, Zhao J, Morse MA, Hobeika A, Ren J, Lyerly HK. Zhao Y, et al. Among authors: hobeika a. Clin Transl Oncol. 2019 Jun;21(6):721-728. doi: 10.1007/s12094-018-1968-3. Epub 2018 Oct 29. Clin Transl Oncol. 2019. PMID: 30374838

6

Direct detection of cellular immune responses to cancer vaccines.

Mosca PJ, Hobeika AC, Clay TM, Morse MA, Lyerly HK. Mosca PJ, et al. Among authors: hobeika ac. Surgery. 2001 Mar;129(3):248-54. doi: 10.1067/msy.2001.108609. Surgery. 2001. PMID: 11231452 Review.

7

Monitoring cellular immune responses to cancer immunotherapy.

Morse MA, Clay TM, Hobeika AC, Mosca PJ, Lyerly HK. Morse MA, et al. Among authors: hobeika ac. Curr Opin Mol Ther. 2001 Feb;3(1):45-52. Curr Opin Mol Ther. 2001. PMID: 11249731 Review.

8

Assays for monitoring cellular immune responses to active immunotherapy of cancer.

Clay TM, Hobeika AC, Mosca PJ, Lyerly HK, Morse MA. Clay TM, et al. Among authors: hobeika ac. Clin Cancer Res. 2001 May;7(5):1127-35. Clin Cancer Res. 2001. PMID: 11350875 Review.

9

Quantitating therapeutically relevant T-cell responses to cancer vaccines.

Hobeika AC, Clay TM, Mosca PJ, Lyerly HK, Morse MA. Hobeika AC, et al. Crit Rev Immunol. 2001;21(1-3):287-97. Crit Rev Immunol. 2001. PMID: 11642610 Review.

10

A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment.

Mosca PJ, Hobeika AC, Clay TM, Nair SK, Thomas EK, Morse MA, Lyerly HK. Mosca PJ, et al. Among authors: hobeika ac. Blood. 2000 Nov 15;96(10):3499-504. Blood. 2000. PMID: 11071647 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters